Physician profile
Derek R Johnson
NPI 1750508453
$39,271.92
in general payments reported to CMS, 2019-2025
7 companies · $8,229 in 2025
The $8,229 reported for 2025 was more than what 96% of Diagnostic Radiology providers received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.63 · 2023: $6,489 · 2024: $24K · 2025: $8,229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $24K · Consulting Fee: $7,161 · Honoraria: $4,000 · Food and Beverage: $3,807.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $24,216.01 |
| Consulting Fee | $7,161.25 |
| Honoraria | $4,000.00 |
| Food and Beverage | $3,807.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Telix Pharmaceuticals | $18,579.37 | 2023-2025 | Illuccix |
| Ge Healthcare | $17,305.19 | 2019-2025 | |
| Siemens Medical Solutions USA, INC. | $2,336.75 | 2024-2025 | Biograph Mmr, Magnetom Free.Max, Biograph Vision 600 (8 Ring/64 Ct) |
| Novartis Pharmaceuticals Corporation | $651.80 | 2023 | |
| Voximetry, INC. | $147.40 | 2023 | Torch |
| Progenics Pharmaceuticals, INC. | $139.02 | 2025 | |
| Life Molecular Imaging LTD | $112.39 | 2025 | Neuraceq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Derek Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.